Literature DB >> 8775216

Acellular pertussis vaccines: the final countdown.

H J Schmitt1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8775216     DOI： 10.1007/bf02075753

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  2 in total

1.  Toward safer and more efficient pertussis vaccines.

Authors:  A Wegmann; R Glück
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 2.  Pertussis vaccines--1993.

Authors:  H J Schmitt; S Wagner
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183
  2 in total
  2 in total

1.  Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis.

Authors:  Jeroen Geurtsen; Liana Steeghs; Hendrik-Jan Hamstra; Jan Ten Hove; Alex de Haan; Betsy Kuipers; Jan Tommassen; Peter van der Ley
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

Review 2.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.